Adial Pharmaceuticals, Inc. (ADIL)
NASDAQ: ADIL · Real-Time Price · USD
1.070
+0.020 (1.90%)
At close: Dec 20, 2024, 4:00 PM
1.050
-0.020 (-1.88%)
After-hours: Dec 20, 2024, 7:20 PM EST

Adial Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2015
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2015
Net Income
-13.05-5.12-12.73-19.42-10.89-8.59
Upgrade
Depreciation & Amortization
0000.0600
Upgrade
Asset Writedown & Restructuring Costs
---1.55--
Upgrade
Loss (Gain) on Equity Investments
0.190.19----
Upgrade
Stock-Based Compensation
0.91.753.374.242.011.6
Upgrade
Other Operating Activities
4.48-1.831.940.17-0.44
Upgrade
Change in Accounts Payable
0.23-0.160.02-0.350.620.09
Upgrade
Change in Other Net Operating Assets
0.13-0.63-1.191.820.620.12
Upgrade
Operating Cash Flow
-6.69-6.81-11.19-11.95-7.63-6.34
Upgrade
Capital Expenditures
----0.06--
Upgrade
Sale of Property, Plant & Equipment
0.351.5----
Upgrade
Cash Acquisitions
---0.03--
Upgrade
Other Investing Activities
-----0.35-
Upgrade
Investing Cash Flow
0.351.5--0.03-0.35-
Upgrade
Issuance of Common Stock
7.850.759.1313.646.1710.3
Upgrade
Repurchase of Common Stock
--0----
Upgrade
Other Financing Activities
3.383.38---0.56-1.05
Upgrade
Financing Cash Flow
11.234.139.1313.645.619.25
Upgrade
Net Cash Flow
4.89-1.17-2.061.66-2.382.91
Upgrade
Free Cash Flow
-6.69-6.81-11.19-12.01-7.63-6.34
Upgrade
Free Cash Flow Per Share
-1.75-4.78-11.17-16.16-15.31-16.08
Upgrade
Levered Free Cash Flow
-3.4-3.21-4.67-5.33-3.57-3.34
Upgrade
Unlevered Free Cash Flow
-3.4-3.21-4.67-5.33-3.57-3.34
Upgrade
Change in Net Working Capital
-0.710.731.26-1.5-1.13-0.21
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.